Sclerosis multiplex (SM): vizsgálatok itt: Puerto Rico
1 of 6 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Where
- Guaynabo
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- TG Therapeutics, Inc.
See details and how to joinNCT06433752